Impact of the covid-19 pandemic on drug treatment of patients with peripheral arterial disease: An observational cross-sectional study

Heloisa Amaral Braghieri, Marília de Almeida Correia, Juliana Ferreira de Carvalho, Paulo Longano, Nelson Wolosker, Gabriel Grizzo Cucato, Raphael Mendes Ritti-Dias, Hélcio Kanegusuku

Research output: Contribution to journalArticlepeer-review

2 Downloads (Pure)

Abstract

Contexto: A pandemia do Coronavírus 2019 (COVID-19) tem afetado negativamente o comportamento dapopulação. Nesse contexto, o impacto da pandemia da COVID-19 no tratamento medicamentoso dos pacientes comdoença arterial periférica (DAP) e claudicação intermitente (CI) permanece obscuro. Objetivos: Analisar o impactoda pandemia da COVID-19 no tratamento medicamentoso dos pacientes com DAP e CI. Métodos: Neste estudoobservacional transversal, 136 pacientes com DAP e CI, recrutados do nosso banco de dados, responderam por telefoneum questionário envolvendo as seguintes questões: a) cuidados com a COVID-19; b) saúde global; c) tratamento dasdoenças. Posteriormente, os pacientes foram divididos em dois grupos, de acordo com a dificuldade para a aquisiçãodos medicamentos (DAM: dificuldade e SDAM: sem dificuldade), para a comparação da saúde global entre os doisgrupos. Resultados: Dezessete porcento dos pacientes reportaram dificuldades para a aquisição dos medicamentosdurante a pandemia. Uma maior prevalência desses pacientes reportou estar mais triste (56,5% versus 24,8%, p < 0,01)e com mais dificuldades para dormir (56,5% versus 24,8%, p < 0,01) em relação aos pacientes do grupo SDAM. Osgrupos não apresentaram diferenças para o declínio na capacidade de caminhada, ansiedade, estresse e depressão(p > 0,05). Conclusões: Uma maior prevalência de pacientes do grupo DAM reportou estar mais triste e com maisdificuldade para dormir em comparação ao grupo SDAM durante a pandemia da COVID-19. = Background: The Coronavirus 2019 (COVID-19) pandemic has had a negative impact on the population’s behavior. In this context, the effect of the COVID-19 pandemic on drug treatment of patients with peripheral arterial disease (PAD) and intermittent claudication (IC) remains unclear. Objectives: To analyze the impact of the COVID-19 pandemic on drug treatment of patients with PAD and IC. Methods: In this cross-sectional, observational study, 136 patients with PAD and IC were recruited from our database and answered a questionnaire by telephone involving the following questions: a) precautions related to COVID-19; b) general health status; and c) treatment of diseases. Subsequently, patients were divided into two groups according to difficulty in obtaining their drugs (DOD: difficulty obtaining drugs, or NDOD: no difficulty obtaining drugs) and overall health was compared between groups. Results: Seventeen percent of patients reported difficulties with obtaining drugs during the pandemic. A higher proportion of these patients reported being sadder (56.5% vs. 24.8%, P < 0.01) and having more difficulty sleeping (56.5% vs. 24.8%, P < 0.01) than of the patients in the NDOD group (P <0.01). The groups did not differ in terms of impairment of walking capability, anxiety, stress, or depression (P> 0.05). Conclusions: A higher proportion of patients in the DOD group reported being sadder and having greater difficulty sleeping compared to the NDOD group during the COVID-19 pandemic.
Translated title of the contributionImpact of the covid-19 pandemic on drug treatment of patients with peripheral arterial disease: An observational cross-sectional study
Original languagePortuguese
Article numbere20210021
Number of pages6
JournalJornal Vascular Brasileiro
Volume20
DOIs
Publication statusPublished - 25 Jun 2021

Fingerprint

Dive into the research topics of 'Impact of the covid-19 pandemic on drug treatment of patients with peripheral arterial disease: An observational cross-sectional study'. Together they form a unique fingerprint.

Cite this